Indivior Pharmaceuticals Inc (INDV) Valuation — DCF & Advanced Analysis | MarketCI

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Indivior Pharmaceuticals Inc (INDV) Valuation — DCF & Advanced Analysis | MarketCI | MarketCI

INDV

Market Closed

Indivior Pharmaceuticals Inc

NASDAQHealthcare Drug Manufacturers - Specialty & Generic

1.03K employees

CEO: Joseph J. Ciaffoni

Founded: 2014

$38.09

+$0.00(+NaN%)

Market Cap

4.75B

Beta

1.17

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: No specific insights available at this time.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore INDV

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

INDV in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →